Sino Biopharmaceutica Financials

Sino Biopharmaceutica Stock Summary

Sino Biopharmaceutica competes with Silo Pharma, Inventiva, Biocardia, UroGen Pharma, and Dominari Holdings. Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutic is traded on OTC Exchange in the United States.

Sino Biopharmaceutica Key Financial Ratios

There are many critical financial ratios that Sino Biopharmaceutica's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Sino Biopharmaceutical reports annually and quarterly.

Sino Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sino Biopharmaceutica's current stock value. Our valuation model uses many indicators to compare Sino Biopharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sino Biopharmaceutica competition to find correlations between indicators driving Sino Biopharmaceutica's intrinsic value. More Info.Sino Biopharmaceutical Limited is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.16  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sino Biopharmaceutical Limited is roughly  6.45 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sino Biopharmaceutica's earnings, one of the primary drivers of an investment's value.

Sino Biopharmaceutical Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Sino Biopharmaceutica help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sino Biopharmaceutical Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sino Biopharmaceutical Limited based on widely used predictive technical indicators. In general, we focus on analyzing Sino Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sino Biopharmaceutica's daily price indicators and compare them against related drivers.

When running Sino Biopharmaceutica's price analysis, check to measure Sino Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sino Biopharmaceutica is operating at the current time. Most of Sino Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sino Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sino Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sino Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.